Turn Therapeutics (TTRX) Accumulated Expenses (2024 - 2026)

Turn Therapeutics' Accumulated Expenses history runs 3 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Accumulated Expenses changed N/A year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $2.3 million (changed N/A YoY), while the FY2025 annual figure was $2.9 million, up 338.91% from the prior year.
• Accumulated Expenses for Q1 2026 stood at $2.3 million, down from $2.9 million in the prior quarter.
• The five-year high for Accumulated Expenses was $2.9 million in Q4 2025, with the low at $667272.0 in Q4 2024.
• The 3-year median for Accumulated Expenses is $2.3 million (2025), against an average of $2.0 million.
• Peak annual rise in Accumulated Expenses reached 338.91% in 2025, while the deepest fall reached 338.91% in 2025.
• Turn Therapeutics' Accumulated Expenses stood at $667272.0 in 2024, then jumped by 338.91% to $2.9 million in 2025, then retreated by 20.95% to $2.3 million in 2026.
• Business Quant data shows TTRX's Accumulated Expenses at $2.3 million in Q1 2026, $2.9 million in Q4 2025, and $2.3 million in Q3 2025.